CELU

SEC source: 0000899243-23-015863 · doc4.xml · nonDerivative · entry 1

Diamandis Peter · CIK 0001528288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,307,066

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

F2 · balance_after: Includes 199,921 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-23-015878 · doc4.xml · derivative · entry 2

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,778

Underlying: Class A Common Stock · 277,778 shares

Expires 2033-06-14

F3 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-23-015878 · doc4.xml · nonDerivative · entry 1

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,066

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

F2 · balance_after: Includes 199,921 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-23-015882 · doc4.xml · derivative · entry 2

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,778

Underlying: Class A Common Stock · 277,778 shares

Expires 2033-06-14

F3 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-23-015882 · doc4.xml · nonDerivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,066

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

F2 · balance_after: Includes 199,921 RSUs granted under the. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000950170-23-031217 · ownership.xml · nonDerivative · entry 1

Lim Kok Thay · CIK 0001470308 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,222

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale, and which withholding of 10,844 shares was inadvertently omitted from the original Form 4 filed on June 16, 2023,.

F2 · balance_after: Includes 199,921 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-011346 · doc4.xml · nonDerivative · entry 1

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,126

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 224,607 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-011340 · doc4.xml · nonDerivative · entry 1

Beers David C · CIK 0001869583 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,405

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 280,759 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-011343 · doc4.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,148,310

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 98,426 shares underlying RSUs subject to vesting. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. .

SEC source: 0000899243-23-011344 · doc4.xml · nonDerivative · entry 1

Fletcher Kyle · CIK 0001937742 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,799

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 249,462 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-011339 · doc4.xml · nonDerivative · entry 1

Haines John R · CIK 0001867686 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 459,847

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 449,213 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-011336 · doc4.xml · nonDerivative · entry 1

Glover Bradley · CIK 0001867698 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,192

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 337,108 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000950170-23-010087 · ownership.xml · derivative · entry 2

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,084,854

Underlying: Class A Common Stock · 2,084,854 shares

Expires 2028-03-27

F1 · price: On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023.

F1 · derivative.exercise_date: On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023.

SEC source: 0000950170-23-010087 · ownership.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,159,850

F1 · price: On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023.

F2 · balance_after: This includes 131,234 shares underlying restricted stock units subject to vesting.

SEC source: 0000899243-23-010027 · doc4.xml · nonDerivative · entry 1

Fletcher Kyle · CIK 0001937742 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,000

F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 250,036 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-005917 · doc4.xml · nonDerivative · entry 1

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,809

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: These shares represent 232,809 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-005919 · doc4.xml · nonDerivative · entry 1

Beers David C · CIK 0001869583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,011

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: These shares represent 291,011 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-005923 · doc4.xml · nonDerivative · entry 1

Fletcher Kyle · CIK 0001937742 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,170

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: These shares include 256,207 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-005921 · doc4.xml · nonDerivative · entry 1

Haines John R · CIK 0001867686 · Senior Exec Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 465,617

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: These shares represent 465,617 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-005918 · doc4.xml · nonDerivative · entry 1

Glover Bradley · CIK 0001867698 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,076

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: These shares include 345,310 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-23-005916 · doc4.xml · nonDerivative · entry 1

Kilcoyne Adrian · CIK 0001857963 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-23-005063 · doc4.xml · derivative · entry 2

Diamandis Peter · CIK 0001528288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,660,136

Underlying: Class A Common Stock · 1,071,000 shares

Expires 2027-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0000899243-23-005063 · doc4.xml · nonDerivative · entry 1

Diamandis Peter · CIK 0001528288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,107,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 36,145 shares underlying restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-037241 · doc4.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,074,996

F1 · price: This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.715 to $1.7199, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-037162 · doc4.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,064,996

F1 · price: This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.655 to $1.7799, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-037102 · doc4.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,024,996

F1 · price: This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.8498, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-036454 · doc4.xml · nonDerivative · entry 2

Jones Anne · CIK 0001869584 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,154

F3 · shares: Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under the 2021 Plan and does not represent a sale.

F4 · balance_after: Includes 40,388 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-22-036453 · doc4.xml · nonDerivative · entry 1

Fletcher Kyle · CIK 0001937742 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,170

F1 · shares: Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.

F2 · balance_after: Includes 31,207 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-22-032650 · doc4.xml · derivative · entry 1

Kilcoyne Adrian · CIK 0001857963 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,226

Underlying: Class A Common Stock · 66,226 shares

Expires 2032-10-03

F1 · derivative.exercise_date: This option was granted under the Issuer's 2021 Equity Incentive Plan. The shares underlying such option vest and become exercisable as follows: 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter so that it will be vested in full on the four-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0000899243-22-030099 · doc4.xml · derivative · entry 2

SCULLEY JOHN · CIK 0001015816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 768,594 shares

Expires 2027-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0000899243-22-030099 · doc4.xml · nonDerivative · entry 1

SCULLEY JOHN · CIK 0001015816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 804,739

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include 36,145 restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of (i) July 13, 2023, such date being the one-year anniversary of the date of grant, and (ii) the next annual stockholder meeting; in each case subject to the Reporting Person's continuous service with the Issuer through such date

SEC source: 0000899243-22-029784 · doc4.xml · derivative · entry 2

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,287

Underlying: Class A Common Stock · 119,073 shares

Expires 2031-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0000899243-22-029784 · doc4.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,984,996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-22-029203 · doc4.xml · derivative · entry 2

Smith Robin L · CIK 0001365035 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Class A Common Stock · 800,000 shares

Expires 2032-08-16

F2 · derivative.exercise_date: This option is subject to vesting in four equal tranches, based on achievement of certain pre-defined performance targets, and subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0000899243-22-029203 · doc4.xml · derivative · entry 1

Smith Robin L · CIK 0001365035 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Class A Common Stock · 250,000 shares

Expires 2032-08-16

F1 · derivative.exercise_date: This option vested and became exercisable immediately on the grant date.

SEC source: 0000899243-22-026190 · doc4.xml · derivative · entry 2

Jones Anne · CIK 0001869584 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,670

Underlying: Class A Common Stock · 33,670 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026190 · doc4.xml · nonDerivative · entry 1

Jones Anne · CIK 0001869584 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,888

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026205 · doc4.xml · derivative · entry 2

SCULLEY JOHN · CIK 0001015816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026205 · doc4.xml · nonDerivative · entry 1

SCULLEY JOHN · CIK 0001015816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026200 · doc4.xml · derivative · entry 2

Lim Kok Thay · CIK 0001470308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026200 · doc4.xml · nonDerivative · entry 1

Lim Kok Thay · CIK 0001470308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026198 · doc4.xml · derivative · entry 2

Kehler Dean C · CIK 0001322745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026198 · doc4.xml · nonDerivative · entry 1

Kehler Dean C · CIK 0001322745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026194 · doc4.xml · derivative · entry 2

Mazur Marc · CIK 0001361226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026194 · doc4.xml · nonDerivative · entry 1

Mazur Marc · CIK 0001361226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026186 · doc4.xml · derivative · entry 2

Smith Robin L · CIK 0001365035 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026186 · doc4.xml · nonDerivative · entry 1

Smith Robin L · CIK 0001365035 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026206 · doc4.xml · derivative · entry 2

Diamandis Peter · CIK 0001528288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026206 · doc4.xml · nonDerivative · entry 1

Diamandis Peter · CIK 0001528288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026184 · doc4.xml · derivative · entry 2

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.